• State and federal legislation highly focused on drug pricing, patient affordability, rebates and transparency.
• The market continues to consolidate resulting in a continual loss of choice, flexibility and negotiating leverage for employers.
• Biosimilars for the world’s highest-grossing medication, Humira, provide opportunities for cost savings.
• Lower prices for insulin products will benefit individual patients and reduce rebates for plans.

First-class experience for clients each time, every time.

• 4.8 client-satisfaction score on a 5-point scale.
• 84 Net Promoter Score
• 99% of client satisfaction survey respondents would recommend Employers Health to a peer.
• 97% of client satisfaction survey respondents said Employers Health makes the PBM experience better.
• The Employers Health team enhances results and improves the client experience, working behind-the-scenes with CVS and Optum Rx to proactively find solutions for clients.
• Custom clinical and utilization management solutions to meet plan sponsors’ needs.

Helping clients achieve their goals by minimizing and flattening trend.

• Employers Health legal and PBM experts negotiate one of the most competitive deals in the industry.
• Annual pricing negotiations offset drug inflation and contribute to single-digit trend.
• Integration of Rx claims with medical carrier.
• Annual claims audit by a third-party auditor, of which findings and recoveries attributed to specific plans are passed back 100%.
• 6-8% minimum average annual pricing improvement.

A growing client base and team drive greater value.

• 60 new clients.
• 350+ plan sponsors, in 40 states, covering more than 1.6 million lives.
• New clients added $550 million in pharmacy spend bringing our total spend to $3.5 billion.
• Review of high-cost claims by Employers Health clinical pharmacists on a weekly basis.
• Improved care for patients with chronic diseases.
• Elimination of waste, ensuring appropriate use and excluding high-price, low-value drugs.